Welcome to our dedicated page for Mint Incorporation news (Ticker: MIMI), a resource for investors and traders seeking the latest updates and insights on Mint Incorporation stock.
Mint Incorporation Limited (NASDAQ: MIMI) is a Hong Kong-based interior design, fit-out, engineering, and technology company whose Class A ordinary shares trade on the Nasdaq Capital Market. This news page aggregates company announcements, market disclosures, and other coverage related to Mint and its operations in interior design, engineering works, and smart facility management.
Readers can follow corporate and capital markets updates, such as Mint’s initial public offering of Class A ordinary shares, Nasdaq listing developments, and notices regarding compliance with Nasdaq listing rules, including minimum bid price requirements. The company also issues news about shareholder matters, including voluntary lock-up agreements entered into by significant shareholders and changes in share classes and voting rights.
News items highlight operational developments across Mint’s subsidiaries. These include appointments to provide routine repairs, maintenance, and air-conditioning services for commercial clients through Matter International Limited, as well as group reorganizations and the addition of subsidiaries engaged in engineering works, smart facility management, software and application development, and robotics design. Announcements about the launch of Axonex Intelligence Limited and Axonex Intelligence Pte. Ltd., and the formation of Axonex Robotics Limited with AIMO (HK) Limited, illustrate Mint’s expansion into robotics, IoT, AI analytics, and smart facility management solutions.
Investors and observers can use this page to review transactional and structural news, including internal group reorganizations, subsidiary name changes, and joint venture formations. By checking this feed regularly, users can see how Mint’s interior design and fit-out business in Hong Kong is complemented by its technology-focused subsidiaries and how these developments are communicated through official press releases and related news coverage.
Mimi's Rock Corp. (TSXV:MIMI) and Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) have launched Dr. Tobias Beta Blend, a dietary supplement aimed at enhancing immune support and promoting skin and eye health. Available exclusively on Amazon and DrTobias.com, the product leverages Avivagen’s proprietary OxC-beta™ technology. Retailing at USD $29.97, this collaboration is expected to meet strong consumer demand, particularly in light of heightened awareness of immune health due to COVID-19.